Oppenheimer Asset Management’s Inogen INGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-14,391
Closed -$132K – 1158
2024
Q4
$132K Sell
14,391
-902
-6% -$8.44K ﹤0.01% 1125
2024
Q3
$148K Buy
15,293
+34
+0.2% +$357 ﹤0.01% 1135
2024
Q2
$124K Buy
15,259
+243
+2% +$1.88K ﹤0.01% 1134
2024
Q1
$121K Buy
+15,016
New +$106K ﹤0.01% 1067
2023
Q4
– Sell
-16,024
Closed -$83.6K – 1161
2023
Q3
$83.6K Buy
16,024
+76
+0.5% +$540 ﹤0.01% 1119
2023
Q2
$184K Sell
15,948
-8
-0.1% -$94 ﹤0.01% 1072
2023
Q1
$199K Buy
15,956
+247
+2% +$4.73K ﹤0.01% 1058
2022
Q4
$310K Buy
15,709
+2,999
+24% +$64.6K 0.01% 957
2022
Q3
$309K Buy
+12,710
New +$351K 0.01% 946
2022
Q2
– Sell
-6,306
Closed -$204K – 1180
2022
Q1
$204K Buy
+6,306
New +$198K ﹤0.01% 1128
2020
Q2
– Sell
-2,859
Closed -$148K – 1249
2020
Q1
$148K Sell
2,859
-242
-8% -$11.6K ﹤0.01% 1028
2019
Q4
$212K Sell
3,101
-18
-0.6% -$1.13K ﹤0.01% 1049
2019
Q3
$149K Sell
3,119
-283
-8% -$14.8K ﹤0.01% 1103
2019
Q2
$227K Buy
3,402
+3,280
+2,689% +$250K 0.01% 1023
2019
Q1
$12K Buy
122
+53
+77% +$6.61K ﹤0.01% 1484
2018
Q4
$9K Buy
+69
New +$11.4K ﹤0.01% 1515

Other funds holding INGN

Oppenheimer Asset Management's INGN Position: Q1 2025 in Review

Oppenheimer Asset Management sold out of Inogen (INGN) in Q1 2025, closing a stake of 14,391 shares — an estimated $132K sold.

Oppenheimer Asset Management first reported a position in INGN in Q4 2018 and held it in 16 quarters. The position peaked at $310K in Q4 2022. 128 funds tracked by Wall St. Rank hold INGN as of Q1 2025.

  • Oppenheimer Asset Management reported no remaining Inogen position as of Q1 2025 after selling out during the quarter.
  • Oppenheimer Asset Management sold 14,391 Inogen shares in Q1 2025, an estimated $132K.
  • Oppenheimer Asset Management first reported a position in Inogen in Q4 2018 and held it in 16 quarters.
  • Oppenheimer Asset Management's Inogen position peaked at $310K in Q4 2022.
  • 128 funds tracked by Wall St. Rank held Inogen as of Q1 2025.

Based on Oppenheimer Asset Management's 13F filing for Q1 2025, filed 23 Apr 2025.